The verdict
Our read at a glance.
Whether hCG's approved endocrine and fertility uses support the separate weight-loss and testosterone or performance claims commonly attached to it.
- The signal
- The approved uses, including induction of ovulation and treatment of hypogonadotropic hypogonadism, rest on established endocrine pharmacology and long clinical use. For weight loss, controlled studies and regulators have found no benefit beyond a very low calorie diet alone, and the FDA has acted against over-the-counter hCG weight-loss products.
- The unknown
- Less about whether hCG works for its approved endocrine uses, which is established, and more about how persistently the weight-loss and performance claims survive despite negative evidence and regulatory action.
- Our read
- Two separate stories under one name. hCG is a real, approved endocrine and fertility drug, and at the same time the hCG diet is a long-debunked claim the FDA has acted against. The error to avoid is letting the legitimate uses lend credibility to the weight-loss and performance claims.
The mechanism
How it works.
hCG is a glycoprotein hormone normally made by the placenta in pregnancy. It binds the LH/hCG receptor on the gonads, the same receptor luteinizing hormone uses, and switches on gonadal hormone production. In women this triggers the final maturation and release of an egg, and in men it drives the testes to make testosterone, which is the basis for its approved fertility and hypogonadism uses. It has no mechanism that burns fat, and the hCG diet claims fail in controlled studies.
Safety & regulatory boundary
The consequential part.
The FDA has stated that over-the-counter hCG products marketed for weight loss are illegal and that homeopathic hCG weight-loss products are fraudulent. Approved hCG products such as Pregnyl and Novarel are prescription drugs for defined endocrine and fertility uses and carry warnings including thromboembolism and ovarian hyperstimulation. Approved injectable hCG is not the same as compounded, research-labeled, or homeopathic hCG products, and the approved endocrine uses do not validate weight-loss or performance claims.
What's next
What we're watching.
Continued FDA enforcement against weight-loss hCG products, and whether fertility and hypogonadism evidence stays distinct from diet and bodybuilding claims.
Context
Why this is discussed.
hCG is discussed in two very different worlds: approved fertility and endocrine medicine, and the popular but unsupported hCG diet and bodybuilding scenes.
The evidence base
22 cited references.
Regulatory & labels2
NuCare Pharmaceuticals,Inc. (FDA label) · 2025
Fresenius Kabi USA, LLC (FDA label) · 2025
Registered trials8
ClinicalTrials.gov · NA · COMPLETED · 2025-12-09
ClinicalTrials.gov · COMPLETED · 2008-03
ClinicalTrials.gov · PHASE2 · ACTIVE_NOT_RECRUITING · 2023-11-23
ClinicalTrials.gov · PHASE3 · RECRUITING · 2023-03-21
ClinicalTrials.gov · NOT_YET_RECRUITING · 2026-12-30
ClinicalTrials.gov · NOT_YET_RECRUITING · 2026-12-30
ClinicalTrials.gov · EARLY_PHASE1 · NOT_YET_RECRUITING · 2026-10-01
ClinicalTrials.gov · EARLY_PHASE1 · NOT_YET_RECRUITING · 2026-08-03
Indexed literature (PubMed)12
Hsia LH et al. · J Assist Reprod Genet · 2023
Alexander EC et al. · Eur J Endocrinol · 2024
Bobdiwala S et al. · BJOG · 2019
Beebeejaun Y et al. · Fertil Steril · 2025
Solangon SA et al. · Acta Obstet Gynecol Scand · 2023
Peris M et al. · Am J Obstet Gynecol · 2024
McClamrock HD · Clin Obstet Gynecol · 2003
Schüler-Toprak S et al. · Int J Mol Sci · 2017
Murugesu S et al. · J Gynecol Obstet Hum Reprod · 2023
Xie Q et al. · Reprod Biol Endocrinol · 2024
Skogler J et al. · Pregnancy Hypertens · 2023
Albright BB et al. · Obstet Gynecol · 2020
Keep reading